| |
| |
|
| Insider
Information: |
Wang Xiaodong |
| Relationship: |
Chair, Scientific Advi... |
| City: |
Camana Bay, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,568,430 |
|
|
Indirect Shares
|
5,186,590 |
|
|
| Direct
Value |
$870,679,715 |
|
|
|
Indirect Value
|
$810,975,212 |
|
|
| Total
Shares |
10,755,020 |
|
|
| Total
Value |
$1,681,654,927 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -49.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beigene Ltd |
BGNE |
Chair, Scientific Advi... |
2024-06-05 |
5,568,430 |
2024-06-05 |
5,186,590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-06-22 |
4 |
AS |
$180.37 |
$906,673 |
D/D |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-06-23 |
4 |
AS |
$185.58 |
$1,118,298 |
I/I |
(6,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-07-01 |
4 |
AS |
$189.19 |
$924,572 |
D/D |
(4,847) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-07-07 |
4 |
AS |
$200.00 |
$1,200,000 |
I/I |
(6,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-07-20 |
4 |
AS |
$249.60 |
$1,259,896 |
D/D |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-07-20 |
4 |
AS |
$249.78 |
$3,015,740 |
I/I |
(12,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-08-10 |
4 |
AS |
$208.91 |
$844,229 |
I/I |
(4,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-09-17 |
4 |
AS |
$260.26 |
$1,301,356 |
I/I |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-09-25 |
4 |
AS |
$280.29 |
$1,402,116 |
I/I |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-10-05 |
4 |
AS |
$300.00 |
$1,500,000 |
I/I |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-10-16 |
4 |
AS |
$320.00 |
$1,600,000 |
I/I |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2021-07-01 |
4 |
AS |
$342.68 |
$1,687,852 |
D/D |
(4,848) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2021-11-08 |
4 |
AS |
$343.10 |
$1,575,202 |
D/D |
(4,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2022-08-05 |
4 |
AS |
$186.69 |
$969,272 |
I/I |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2022-08-05 |
4 |
AS |
$186.56 |
$969,256 |
D/D |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2022-08-08 |
4 |
AS |
$200.38 |
$1,219,594 |
D/D |
(6,060) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2022-11-15 |
4 |
AS |
$210.14 |
$417,541 |
I/I |
(1,987) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2022-12-13 |
4 |
AS |
$210.59 |
$636,723 |
I/I |
(3,013) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-01-09 |
4 |
AS |
$250.00 |
$225,000 |
D/D |
(900) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-01-10 |
4 |
AS |
$250.09 |
$400,152 |
D/D |
(1,600) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-01-11 |
4 |
AS |
$250.39 |
$631,647 |
D/D |
(2,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-01-12 |
4 |
AS |
$260.31 |
$1,302,585 |
I/I |
(5,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2023-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(172,372) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Director |
– • – |
2017-05-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,841 |
224,372 |
0 |
- |
|
| BGNE |
Beigene Ltd |
Chair, Scientific Advisory Brd |
– • – |
2020-12-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,244,542 |
1,244,542 |
0 |
- |
|
80 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
